Daiwa Securities Group Inc. - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 95 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q2 2019. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q3 2022$01830.0%0.00%
Q2 2022$01830.0%0.00%
Q1 2022$01830.0%0.00%
Q4 2021$01830.0%0.00%
Q3 2021$0
-100.0%
1830.0%0.00%
Q2 2021$1,000
-50.0%
1830.0%0.00%
Q1 2021$2,0000.0%1830.0%0.00%
Q4 2020$2,000
-60.0%
183
-58.4%
0.00%
Q3 2020$5,000
+25.0%
4400.0%0.00%
Q2 2020$4,0000.0%4400.0%0.00%
Q1 2020$4,0000.0%440
+20.5%
0.00%
Q4 2019$4,000
+100.0%
365
-11.2%
0.00%
Q3 2019$2,000
-60.0%
4110.0%0.00%
Q2 2019$5,000
+150.0%
4110.0%0.00%
Q1 2019$2,0004110.00%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q2 2019
NameSharesValueWeighting ↓
Sonic Fund II, L.P. 4,112,355$85,866,00042.72%
Versant Venture Management, LLC 7,003,892$146,241,265,00021.01%
ACUTA CAPITAL PARTNERS, LLC 1,746,500$36,467,00010.54%
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 480,000$10,022,0005.33%
Ghost Tree Capital, LLC 900,000$18,792,0004.96%
RTW INVESTMENTS, LP 6,790,027$141,776,0003.99%
RA Capital Management 7,801,641$162,898,0003.17%
Avoro Capital Advisors LLC 7,585,000$158,375,0003.13%
FRAZIER MANAGEMENT LLC 1,437,028$30,005,0002.64%
Soleus Capital Management, L.P. 218,723$4,566,0002.60%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders